College of Health

D. B. Jump, Botolin, D., Wang, Y., Xu, J., Demeure, O., and Christian, B., “Docosahexaenoic acid (DHA) and hepatic gene transcription.”, Chem Phys Lipids, vol. 153, no. 1, pp. 3-13, 2008.

D. Botolin, Wang, Y., Christian, B., and Jump, D. B., “Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways.”, J Lipid Res, vol. 47, no. 1, pp. 181-92, 2006.

Y. Wang, Torres-Gonzalez, M., Tripathy, S., Botolin, D., Christian, B., and Jump, D. B., “Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.”, J Lipid Res, vol. 49, no. 7, pp. 1538-52, 2008.

D. B. Jump, Botolin, D., Wang, Y., Xu, J., Christian, B., and Demeure, O., “Fatty acid regulation of hepatic gene transcription.”, The Journal of nutrition, vol. 135, no. 11, pp. 2503-6, 2005.

Y. Wang, Botolin, D., Xu, J., Christian, B., Mitchell, E., Jayaprakasam, B., Nair, M. G., Nair, M., Peters, J. M., Peters, J. M., Busik, J. V., Busik, J., L Olson, K., and Jump, D. B., “Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.”, Journal of lipid research, vol. 47, no. 9, pp. 2028-41, 2006.

J. Xu, Christian, B., and Jump, D. B., “Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.”, J Biol Chem, vol. 281, no. 27, pp. 18351-62, 2006.

Y. Wang, Botolin, D., Christian, B., Busik, J., Xu, J., and Jump, D. B., “Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases.”, J Lipid Res, vol. 46, no. 4, pp. 706-15, 2005.